These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3033261)

  • 1. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    Rickinson AB; Young LS; Rowe M
    J Virol; 1987 May; 61(5):1310-7. PubMed ID: 3033261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
    J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B; Robertson E; Kieff E
    J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
    J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    Cohen JI; Picchio GR; Mosier DE
    J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
    J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-specific T-cell recognition of B-cell transformants expressing different EBNA 2 antigens.
    Wallace LE; Young LS; Rowe M; Rowe D; Rickinson AB
    Int J Cancer; 1987 Mar; 39(3):373-9. PubMed ID: 3493225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.